Tanja Lövgren

9PUBLICATIONS
48CO-AUTHORS
Tumour immunologyMolecular targetsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 30, 2026
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8+ T cells.

|Apr 29, 2026
Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial.

|Feb 16, 2026
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

O Hamid, V Ekström-Rydén, I Mehmi

|Aug 04, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.

Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård

|Sep 14, 2020
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination.

Tanja Lövgren, Maria Wolodarski, Stina Wickström

|Apr 19, 2020
The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones.

Isabel C Poschke, Jessica C Hassel, Aaron Rodriguez-Ehrenfried

Pageof 2

Frequent Collaborators

5 joint publications

Angelica Loskog

3 joint publications

Rolf Kiessling

3 joint publications

Gustav J Ullenhag

3 joint publications

Jessica Wenthe